PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsDrug companies and universities team up to create European stem cell bank

BioNews

Drug companies and universities team up to create European stem cell bank

Published 7 December 2012 posted in News and appears in BioNews 685

Author

Paola Quattroni

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).

Ten drugs companies and 23 European universities will work to develop a stem cell bank that researchers will use in fundamental disease research and to test potential new medicines...

Ten drugs companies and 23 European universities will work
to develop a stem cell bank that researchers will use in fundamental disease
research and to test potential new medicines.

Called StemBANCC, the project was
initiated and will be coordinated by the University of Oxford and the
Swiss-based pharmaceutical company Roche. It will receive €55.6 million in funding
over five years, with €26 million coming from the European Union's Innovative
Medicines Initiative. The participating drugs firms will furnish €21 million in
'in kind' contributions.

Martin Graf, Head of the Stem Cell Platform and coordinator
of the project at Roche, says: 'The aim of StemBANCC is to generate and
characterise 1,500 high quality human induced pluripotent stem cell [iPSC] lines
derived from 500 patients that can be used by researchers to study a range of
diseases, including diabetes and dementia'­.

Induced pluripotent stem cells are created by reprogramming
normal adult cells so that they enter a state similar to that found in
embryonic stem cells and then can be made to grow into other types of cell. So
cells from patients' blood or skin can be used to generate other specialised cell
types - heart cells or neurons, for example - relevant to the disease being
investigated. These cells can then be used in laboratory tests for early stage
drug development.

Because such cells contain patients' genes, they might include
genes implicated in the disease of interest. Dr Zameel Cader, a consultant neurologist at
the University of Oxford and principal scientist of StemBANCC says that iPSCs represent
'the perfect platform for finding drugs. It's superior because we are looking
directly at human cells from the patient, capturing the genetic complexity of
the disease'.

Currently, new compounds are likely to be screened in lab
cell lines that are amenable to study but bear little resemblance to patients'
cells.

Dr Sally Cowley, also from the University of Oxford, adds: 'Because the stem cells can be expanded
indefinitely, we can essentially produce an infinite number of these
patient-derived cells to work with. They can be stored, shipped around the
world, and potentially made accessible to any researcher anywhere'.

The
StemBANCC project will initially focus on disorders of the nervous system, such as neuropathic
pain and Alzheimer's and Parkinson's diseases, psychiatric disorders like
schizophrenia and bipolar disorder, as well as diabetes.

Related Articles

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
22 May 2017 • 2 minutes read

Large bank of human stem cell lines made in Europe

by Shaoni Bhattacharya

One of the world's largest sets of human stem cell lines from healthy people was unveiled last week...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
13 September 2013 • 3 minutes read

Back up your stem cells for £40,000

by Dr Antony Starza-Allen

A Singaporean-based company has become the first company to offer iPS cell banking to the public...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
13 March 2013 • 2 minutes read

US embryonic stem cell bank to close after only four years

by Ruth Retassie

The University of Massachusetts (UMass) Stem Cell Bank, opened in response to restrictions on the funding of human embryonic stem cell (hESC) research in the USA, will close after just four years in existence when it runs out of public funding later this year....

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
25 February 2013 • 2 minutes read

US sperm and egg donors may be unconsenting contributors to stem cell science

by Maria Sheppard

Human embryonic stem cell lines approved for federal funding in the USA, may have been derived from sperm or eggs of unconsenting donors...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
11 January 2013 • 2 minutes read

Safety of stem cells supported by mouse study

by Dr Anna Cauldwell

Tissue derived from induced pluripotent stem cells causes 'limited or no immune response' in mice, a study published in Nature has found...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
29 November 2012 • 1 minute read

New stem cell lab to open in Cape Town

by Dr Maria Teresa Esposito

A new stem cell lab in Cape Town, South Africa, has renewed the debate over stem cell banking in the country...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
17 October 2012 • 1 minute read

UK and US stem cell bank tie up announced

by MacKenna Roberts

The UK Stem Cell Bank (UKSCB) has announced it has forged an affiliation with the recently established University of Massachusetts (UMASS) Human Stem Cell Bank and Registry for the exchange of stem cell technology and expertise. The banks will collaborate on various aspects of stem cell banking, including best practice standards and the delivery of stem cell lines for clinical use...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 1 minute read

US hospital-biotechnology partnership to offer stem cell banking

by Dr Antony Starza-Allen

A hospital in the US has teamed up with a biotechnology company to allow pregnant women to bank their baby's cord blood and placental stem cells in what is thought to be the first official programme to encourage stem cell banking in the country. The Saint Barnabas...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 2 minutes read

Second US company offers to distribute ACT's new stem cells

by Heidi Nicholl

American biotech company WiCell, based in Wisconsin, has agreed to help distribute any stem cell lines created using a new, still controversial, technique developed by Advanced Cell Technologies (ACT). The new technique was reported in Nature on 24 August and describes a 'proof of principle' that stem...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Improved prenatal test may better detect genetic diseases

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856